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The rising prevalence of heart failure in response to changing demographics and the modified 
natural history of disease in response to effective treatments is well described. For the individual 
and family, heart failure has a wide-reaching personal impact, with reduced quality of life and 
function within society, and a prolonged dependence on healthcare services. This high cost to the 
individual and to healthcare services is projected to increase further, yet there is little emphasis in 
practice on solutions to prevent or manage its implications. A recently published systematic review 
of studies from ten countries across Europe and North America investigating cost-of-illness in heart 
failure presented important concerns.1  During the course of heart failure, the costs of medical care 
are largely driven by hospital admission and are highest in the year after diagnosis and in the last 6 
months of life. The most common predictors for higher care costs are comorbidity (the cause of 
around three-quarters of readmissions in people with heart failure) and advanced stage of disease. 
Management of people with New York Heart Association Class IV heart failure accounts for 70% of 
total annual heart failure costs.1    
While the first peak in costs following diagnosis is intuitively appropriate, the second peak at the end 
of life raises important concerns about inappropriate admissions and the use of invasive, 
burdensome and futile interventions. People with advanced disease are in double jeopardy: if 
inappropriate care is being received, they may not receive the care which would be helpful to them 
and their families. Evidence-based practice consists of three pillars: the best quality relevant 
research evidence, clinician expertise and patient values. Prioritisation of clinical service time for life-
prolonging interventions to the exclusion of an assessment of patient and family unmet needs leads 
to the omission of the third pillar. The second pillar is needed – for clinicians to interpret the 
relevance of trial results to the older patient with multi-morbid advanced disease sitting in front of 
them in clinic. These patients are those at most risk of admission in the last 6 months and the 
population most often excluded from clinical trials. 
This problem is not peculiar to people with heart failure. Over the past decade advance care 
planning has been introduced across a range of diseases to “help ensure that people receive medical 
care that is consistent with their values, goals and preferences during serious and chronic illness.’’2 
Advance care planning is defined as “… a process that supports adults at any age or stage of health in 
understanding and sharing their personal values, life goals, and preferences regarding future medical 
care.”2 Preliminary evidence from a systematic review of 113 papers suggests benefits with regard to 
increased concordance with patients’ end of life wishes and reduced health service costs.3 Despite 
the escalating clinical problem and enough published research to furnish a review of 80 systematic 
reviews representing 1,660 individual articles, implementation in clinical practice remains partial or 
non-existent in heart failure care.4 
Very little is published in heart failure. A systematic review of the effectiveness of ACP in heart 
failure with regard to hospital admissions found eight papers of which only four were randomised 
controlled trials (RCTs).5 Only three of the RCTs were evaluation phase trials and in all of these ACP 
was delivered as a component, and in the context, of multi-disciplinary specialist palliative care. The 
effectiveness of ACP per se was therefore not the primary objective of the trials. Findings indicated a 
reduction in hospital admissions but the direct contribution of ACP alone cannot be assessed. One 
feasibility trial was a cardiology-led ACP intervention.6 Since this review, a further feasibility non-
randomised study from a cardiology-led palliative care service which included an ACP with medical 
ceilings of intervention reported findings.7 Both cardiology-led studies6;7 showed preliminary 
evidence of benefit with reduction in hospital admission. Cardiology-led, rather than specialist 
palliative care-led, ACP must signal the way forward: i) ACP may be pertinent to discussion of 
treatment plans at any stage of health irrespective of stage of heart failure, ii) cardiology and 
primary care teams can be trained effectively in ACP and thus referral of all patients to specialist 
palliative care for ACP is unnecessary, iii) the sheer numbers of patients involved are too great for 
the limited resource of specialist palliative care and would be unsustainable, iv) ACP is often a useful 
doorway through which a referral to specialist palliative care is made for those with persistent and 
severe symptoms, or where care/death in hospice is preferred – a reluctance to engage with ACP 
often goes hand-in-hand with poor access to specialist palliative care. 
 
So, why is systematic implementation of ACP in heart failure services such a rarity? In this issue 
Schichtel and colleagues present a literature review and meta-analyses examining the effectiveness 
of interventions to increase completion of ACP in heart failure practice.[Schichtel et al reference] 
From the 13 included RCTs, they demonstrate that interventions targeting patients (support and 
education about ACP and training in how to raise the subject and discuss with their clinicians), 
clinicians (education) and systems (using IT systems to trigger reminders to clinicians) improve 
completion of ACP. Interventions which included a number of targets had a larger effect size. These 
findings are consistent with the broader chronic illness literature presented by Jimenez et al.4 They 
discussed how barriers exist at all levels from the patient and family, service providers, and 
institutional through to organisational and policy. All of these need to be addressed if ACP is to be 
implemented routinely (see Table 1). Of note, the cardiology-led palliative care service7 involved 
serious multi-level commitment: additional training and support for the lead clinicians including for 
job planning to allow time; reconfiguring of clinics to form an advanced disease clinic which 
functions across hospital and community; and the joint commitment of the regional health board 
and two major national charities (Greater Glasgow and Clyde Health Board, British Heart Foundation 
and Marie Curie). 
 
Table 1. Elements needed for successful implementation of ACP. (Adapted from Jimenez et al.) 
  
Main Factor Specific Elements 
Whole-system strategic 
approach 
 Interventions target patients, family carers and clinicians 
concurrently 
 Cultural and social issues at all levels (individual, institution 
and society) and targets (patients and families, clinicians, 
commissioners and policy makers) must be addressed to 
ensure that honest and difficult, but supported, 
conversations are legitimatised as a core component of 
service 
 Address structural constraints to support delivery (e.g. 
consider reconfiguration of service delivery, and ensure clear 
understanding of legal issues) 
 Ensure funding and sufficient skilled staff including medical 
personnel 
Components of effective ACP 
programmes 
 Interactive information sharing with knowledgeable and 
skilled person to allow discussion of concerns 
 Facility for repeated conversations for ongoing patient 
education and allow completion of advance directives or ACP 
records 
 Implement and evaluate across sites and ensure 
communication between healthcare settings 
 Ensure processes for conflict resolution (ethics committees, 
mediation, guidelines, advanced communication skills 
training) 
Further innovations  Use of IT solutions to facilitate scale (training, reminders, 
communication between healthcare settings) 
 Work to facilitate storage and retrieval of documentation 
across IT systems supporting electronic health care records 
 Use an agreed, common ACP record across disciplines and 
health care settings with flexibility for disease specific issues 
such as device therapy (e.g. especially important for the 
patient with multi-morbidity) 
 Moving from a hospital-led to a community-led programme 
will further facilitate communication between specialties, 
particularly where the patient’s overall care is co-ordinated 
through primary care  
 
 
In a healthcare system which, in many places, feels overwhelmed, and in a specialty where exciting 
new interventions to prolong life continue to arrive at a dizzying rate, this message is timely given 
the impending socio-economic and personal disasters if not addressed. It is also deeply 
uncomfortable for many. The “between-the-lines” messages conveyed by Schichtel et al are 
disturbing.   It is disturbing that it is necessary to train, educate and support patients to discuss such 
vital issues with their doctors. This necessity is consistent with a still pervading attitude in clinical 
practice – particularly medical - that communication skills are “soft”, despite the implication of poor 
skills in complaints representing both enormous personal cost to the patient and costs to services. 
Why is advanced communication skills training not a mandatory part of specialist cardiology training 
and regularly updated no matter how senior the practitioner to ensure they model good practice to 
their teams? How can clinicians, invested in the patient’s survival and personally distressed by 
challenging but honest conversations, be supported not to perpetuate a conspiracy of unqualified 
optimism? Failure to reframe hopes from unrealistic to realistic potentially denies patient and 
families much needed support, and risks subjecting them to futile treatments. The third pillar of 
evidence-based practice can only support decision making when the patient and family are fully 
appraised, and their views actively and sensitively sought. This “hard” skill must be given its place as 
a core component of person-centred care that is every clinician’s responsibility to provide. 
 
The literature published thus far gives us clear pointers as to how to implement ACP but heart failure 
care has been slow to come to the table. For too long, the unpredictable nature of heart failure has 
been used as a reason to avoid an exploration of a patient’s values to provide a frame within which 
to individually tailor heart failure management, taking both best and worst case scenarios into 
account. Surely, if there is any uncertainty, then, by definition, there must be a risk of future 
deterioration which should be addressed. As Braun et al state so succinctly in their American Heart 
Association/American Stroke Association Policy Statement, “Instead of serving as a reason to avoid 
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